loader
Please Wait
Applying Filters...

Minakem Generic APIs Minakem Generic APIs

X

List of catequentinib NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Lianyungang Runzhong Pharmaceutical Co., Ltd. (2)

filter

01 Catequentinib Dihydrochloride (1)

02 Catequentinib Hydrochloride (1)

filter

01 China (2)

URL Supplier Web Content
Catequentinib Dihydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
61662-0018
2022-03-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Catequentinib Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
61662-0016
2021-06-30
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1058156-90-3 / Anlotinib API manufacturers, exporters & distributors?

Anlotinib manufacturers, exporters & distributors 1

50

PharmaCompass offers a list of Anlotinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Anlotinib manufacturer or Anlotinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Anlotinib manufacturer or Anlotinib supplier.

PharmaCompass also assists you with knowing the Anlotinib API Price utilized in the formulation of products. Anlotinib API Price is not always fixed or binding as the Anlotinib Price is obtained through a variety of data sources. The Anlotinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Anlotinib

Synonyms

1058156-90-3, Catequentinib, Al3818, Al-3818, Al 3818, Gkf8s4c432

Cas Number

1058156-90-3

Unique Ingredient Identifier (UNII)

GKF8S4C432

About Anlotinib

Anlotinib is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.

catequentinib Manufacturers

A catequentinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of catequentinib, including repackagers and relabelers. The FDA regulates catequentinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. catequentinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of catequentinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

catequentinib Suppliers

A catequentinib supplier is an individual or a company that provides catequentinib active pharmaceutical ingredient (API) or catequentinib finished formulations upon request. The catequentinib suppliers may include catequentinib API manufacturers, exporters, distributors and traders.

click here to find a list of catequentinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

catequentinib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing catequentinib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for catequentinib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture catequentinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain catequentinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a catequentinib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of catequentinib suppliers with NDC on PharmaCompass.

catequentinib Manufacturers | Traders | Suppliers

catequentinib Manufacturers, Traders, Suppliers 1
16

We have 1 companies offering catequentinib

Get in contact with the supplier of your choice:

  1. Lianyungang Runzhong Pharmaceutical Co Ltd
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY